联环药业: 非金融企业债务融资工具信息披露事务管理办法（2025年8月修订）

Core Points - The document outlines the information disclosure management measures for Jiangsu Lianhuan Pharmaceutical Co., Ltd. regarding the issuance of non-financial corporate debt financing instruments in the interbank bond market [1][2][3] Group 1: General Principles - The company must ensure that disclosed information is true, accurate, complete, and timely, without any false records or misleading statements [3][4] - The company’s board of directors and senior management are responsible for the authenticity and completeness of the information disclosed [5][6] Group 2: Disclosure Management - The chairman of the company is designated as the person responsible for managing the information disclosure related to debt financing tools [7] - The finance department is responsible for the daily management of information disclosure related to debt financing tools [4][5] Group 3: Disclosure Requirements - The company must disclose specific documents before issuing debt financing instruments, including audited financial reports for the last three years and a fundraising prospectus [8][9] - The company is required to disclose the results of the issuance no later than the first trading day of the debt financing instruments [9][10] Group 4: Major Events Disclosure - The company must disclose any major events that may affect its ability to repay debt or investor rights within two working days of the occurrence [12][11] - Major events include changes in company name, significant operational changes, and changes in key personnel [11][12] Group 5: Confidentiality Measures - The company must implement measures to manage and control the disclosure of non-public information, ensuring that unauthorized individuals do not leak sensitive information [17][18] Group 6: Internal Control and Accountability - The company must establish internal controls for financial management and accounting, ensuring compliance with relevant laws and regulations [39][40] - Violations of the disclosure management measures may lead to accountability under the company's internal management system [42]